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Received 19 April 2007; received in revised form 18 November 2007; accepted 28 November 2007AbstractMycoplasma gallisepticum is the primary agent of chronic respiratory disease causing important economic losses in the
poultry industry. Serological monitoring is essential to maintain mycoplasma-free breeder flocks and often complicated by the
cross-reactions between different mycoplasma species. To overcome serological cross-reactions, a large fragment of the M.
gallisepticum PvpA cytadhesin, species-specific surface-exposed protein, was produced in E. coli as a recombinant protein
(rPvpA336) and used as a potential diagnostic antigen. The rPvpA336 protein possesses 336 mycoplasma-specific amino acids
with relative molecular weight of 44 kDa. A deletion region of 37 amino acids was identified when compared to the wild-type
PvpA protein. Immunoreactivity of the rPvpA336 protein has been demonstrated by Western blot analysis with M.
gallisepticum-positive and -negative chicken sera. Furthermore, an enzymatic rapid immunofiltration assay (ERIFA) prototype
based on the rPvpA336 protein has been developed and its species-specific detection capability has been demonstrated by using
M. gallisepticum and/or M. synoviae-positive and -negative chicken sera. In addition to its species-specificity, the ERIFA
prototype presents certain advantages such as rapidity, field-applicability and cost-effectiveness. Therefore, these advantages
would make the prototype a species-specific rapid diagnostic tool of choice in the field and limited laboratory conditions for
screening M. gallisepticum infections.
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Mycoplasma gallisepticum is the primary agent of
chronic respiratory disease in chickens, and infectious* Corresponding author. Tel.: +90 362 312 19 19x2807.
E-mail address: yurdusev@omu.edu.tr (N. Yurdusev).
0378-1135/$ – see front matter # 2007 Elsevier B.V. All rights reserved
doi:10.1016/j.vetmic.2007.11.028sinusitis in turkeys causing important economic losses
in poultry industry. Colonization of the chicken
respiratory tract by M. gallisepticum is the basis of
the disease and mediated by several cytadhesin-related
molecules such as MGC1 or GapA (Keeler et al.,
1996; Goh et al., 1998), MGC2 (Hnatow et al., 1998),
MGC3 or CrmA (Yoshida et al., 2000) and PvpA.
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breeder flocks, the disease is essentially controlled by
serological monitoring often complicated by the cross-
reactions between different mycoplasma species
(Noormohammadi et al., 1998; Dufour-Gesbert
et al., 2001; Bencina, 2002; Feberwee et al., 2005).
The cross-reactions, due to the presence of identical
antigens or antigenic determinants, have been over-
come by using recombinant fusion proteins including
species-specific domain of M. synoviae (Noormo-
hammadi et al., 1999) and M. meleagridis (Ben
Abdelmoumen Mardassi et al., 2007) as potential
diagnostic antigens.
In the case of M. gallisepticum infections, the PvpA
cytadhesin could be a potential diagnostic antigen of
choice since this surface-exposed protein is accessible
to the host immune response (Boguslavsky et al.,
2000) and its species-specific and immunogenic
properties have clearly been demonstrated (Yogev
et al., 1994). Considering its frequent phase- and size-
variability in expression and among different strains
(Yogev et al., 1994; Levisohn et al., 1995; Bogus-
lavsky et al., 2000), a recombinant PvpA protein
(rPvpA336) was produced as a standard target antigen
and a rapid serodiagnostic prototype based on the
rPvpA336 protein was developed for screening M.
gallisepticum infections in chicken. The immunor-
eactivity and specificity of the rPvpA336 protein as
well as the potential use of the species-specific
diagnostic prototype were discussed.2. Materials and methods
2.1. Bacterial strains and growth conditions,
antibody and chicken sera
Genomic DNA and bacterial lysate were obtained
from M. gallisepticum strain Pendik provided from
Pendik Veterinary Control and Research Institute
(İstanbul, Turkey). E. coli DH5a (Takara Inc., Paris,
France) was grown at 37 8C in LB (Luria-Bertani)
broth. In the case of the transformed E. coli DH5a
strain, LB broth contained 50 mg/ml of ampicillin.
Mouse monoclonal anti-HisTag antibody (His-
probe (H3): sc-8036) purchased from Santa-Cruz
Biotechnology Inc. (California, USA) was used as
positive control of the recombinant protein in Westernblot analysis. Chicken sera were obtained from a
private diagnostic laboratory Protekt (İstanbul, Tur-
key) regularly monitoring M. gallisepticum infection
by using RSA test (rapid serum agglutination) and
ELISA. RSA test antigens were obtained from
Intervet-Turkey (Nobilis MG antigen, İstanbul, Tur-
key) and Pendik Veterinary Control and Research
Institute. ELISA kits were purchased from BioChek
(AN Gouda, Holland) and IDEXX Laboratories, Inc.
(Maine, USA). The chicken sera were tested or
retested with ELISA kits (BioChek) according to the
manufacturers’ instructions for detecting M. synoviae
or M. gallisepticum antibodies.
2.2. PCR amplification and cloning of the pvpA
gene into pCold I vector
pColdI expression vector is used for obtaining
recombinant polyhistidine (HisTag) fusion proteins
(Takara Inc.). pColdI expression vector contains cold
shock protein (cspA) promoter region allowing the
induction of the expression of recombinant proteins
with IPTG (isopropyl-b-D-thiogalactopyranoside) at
15 8C-growth conditions.
M. gallisepticum genomic DNA was purified by
‘‘Genomic DNA Purification Kit’’ (Bio Basic Inc.,
Ontario, Canada) from inactivated bacteria following
the instructions of the manufacturer. For PCR
amplification, forward and reverse primers were
synthesized by Bio Basic Inc. Forward primer (50
GGGCAAGAGCTCAATAAATTAAAAAAAC 30)
contains SacI and reverse primer (50 GCTC-
GGAATTCCCCACCTTATGGTCTTGG 30) contains
EcoRI restriction enzyme sites. PCR amplification was
performed in a 50 ml reaction mixture containing
1.5 mM of MgCl2, 10 PCR buffer, 1 mM of each
dNTP, 30 pmol of each primer, 2 U/ml of Taq DNA
polymerase (Fermentas UAB, Vilnius, Lithuania), and
200 ng of genomic template DNA, in a DNA thermal
cycler. The initial cycle of 5 min of denaturation at
94 8C was followed by 35 cycles of 30 s of denaturation
at 94 8C, 30 s of annealing of the primers at 58 8C,
1 min 40 s of extension at 72 8C, with a final 10 min
extension step at 72 8C. The pvpA336 amplicon was
purified by QIAquick Gel Extraction Kit (Qiagen
GmbH, Hilden, Germany) and digested by EcoRI and
SacI (Fermentas UAB). Cohesive-end ligation of the
restricted amplicon into pColdI vector was performed
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resulting plasmid was designated as pCold-pvpA336.
2.3. DNA sequencing
DNA sequencing was performed with ‘‘ABI 310
Capillary DNA Sequencer’’ (Global Medical Instru-
mentation Inc., Minnesota, USA) and ‘‘ABI PRISM
BigDye Terminator Cycle Sequencing Kit’’ (Applied
Biosystems, California, USA). Initially, pvpA336 gene
fragmentwas amplifiedbyPCRfrompCold-pvpA336 as
template by using forward (50GCACGCCATATCGCC-
GAAAGG 30) and reverse (50 CCAAATGGCAGG-
GATCTTAGATTCTGTGC 30) primers and purified.
The sequencing reaction solution with a volume of 20 ml
consisted of8 ml ofBig Dye Mix (4 ml ofmix and 4 ml of
5 sequencing buffer), 5–20 ng of template, 2 ml of
primer and dH2O. The DNAs were amplified for 25
cycles (10 s at 96 8C, 5 s at 55 8C and 4 min at 60 8C).
Bases not participating in polymerization were removed
from the reaction solution by ‘‘Dye-Ex Kit’’.
2.4. Nucleotide and amino acid sequence data
The nucleotide sequence of the pvpA336 gene and
deduced amino acid sequence of the rPvpA336 protein
obtained from M. gallisepticum strain Pendik have been
deposited in NCBI-GenBank database under the
accession nos. DQ989519.2 and ABJ96344, respec-
tively. For sequence similarity and homology search-
ing, the Blast program at the NCBI web server was used.
2.5. Transformation and expression of
recombinant rPvpA336 protein in E. coli
Competent E. coli DH5a cells were transformed
with the pCold-pvpA336 vector and ampicillin-
resistant transformants were selected in LB broth as
previously described (Sambrook et al., 1989). Single
colony of the transformant was cultured and pCold-
pvpA336 vectors were purified with Mini-prep DNA
Extraction Kit (Qiagen GmbH) and digested with
EcoRI and SacI enzymes to confirm the presence of
pvpA336 insert. Then, the transformants were cultured
until they reached 0.3–0.4 absorbance at 600 nm.
Expression of the recombinant PvpA336 protein was
induced by the addition of IPTG (Fermentas UAB) at a
final concentration of 0.5 mM to the culture. Theincubation was continued at 15 8C for 24 h with
shaking at 200 rpm/min. The cells were collected by
centrifugation at 4000  g for 20 min and washed
three times in 0.15 M NaCl and resuspended in lysis
buffer (125 mM Tris–HCl pH 6.8, 1% SDS). Bacteria
were boiled for 10 min and then centrifuged at
20,000  g for 20 min to discard the cell debris.
2.6. SDS-PAGE and Western blot analysis
Whole cell extracts of M. gallisepticum and the
recombinant E. coli as well as the purified rPvpA336
protein were separated on 10% polyacrylamide gels
(Laemmli, 1970) and stained with coomassie brilliant
blue or electro-transferred to polyvinyldifluoride
(PVDF) membranes (0.2 mm pore size, Immobilon-
P, Sigma–Aldrich, St. Louis, USA) for 1 h at 0.8 mA/
cm2 using a semi-dry transblotter (Towbin et al.,
1979). The membrane strips blocked with 1% gelatin
from cold water fish skin (Sigma–Aldrich) in PBST
(PBST/FG, pH 7.4; 0.1% Tween 20) were incubated
with either chicken sera at a dilution of 1:200 for 1 h or
anti-HisTag Mouse monoclonal antibody (IgG1,
Santa-Cruz) at a dilution of 1:200 for 90 min at room
temperature with gently shaking. The membranes
were then incubated with either AP conjugated Rabbit
anti-chicken IgY (Sigma–Aldrich) or AP conjugated
goat anti-mouse g chain specific (Sigma–Aldrich)
antibody solutions for 1 h at room temperature with
shaking. Color reaction was developed with the
addition of BCIP/NBT-blue liquid substrate system
for membranes (5-bromo-4-chloro-3-indolyl phos-
phate/nitro blue tetrazolium, Sigma–Aldrich) for
10 min and stopped by washing with distilled water.
2.7. Purification of the recombinant rPvpA336
protein
Whole cell extract of the induced bacteria dialyzed
against PTU buffer (phosphate–Tris–urea buffer: 0.1 M
NaH2PO4, 10 mM Tris, 8 M urea pH 8) was mixed with
1 ml of Ni-NTA agarose beads (Ni-nitrilotriacetic acid,
Qiagen) by gently shaking at 200 rpm at room
temperature for 1 h and loaded to the empty column
and washed with PTU buffer pH 6.3. Two-step elution
of the recombinant rPvpA336 protein was performed
with PTU buffer at pH 5.9 and 4.5. The fractions
containing rPvpA336 protein were determined by SDS-
Ö. Büyüktanır et al. / Veterinary Microbiology 129 (2008) 139–149142PAGE. The protein band corresponding to rPvpA336
protein was excised from the polyacrylamide gel and
incubated in the elution buffer (50 mM Tris–HCl,
150 mM NaCl, 0.1 mM EDTA pH 7.5) with shaking.
The rPvpA336 diffused into the elution buffer was
analyzed by SDS-PAGE and then, highly purified
recombinant rPvpA336 protein was used for Western
blot and enzymatic rapid immunofiltration assays.
2.8. Enzymatic rapid immuno-filtration assays
(ERIFA)
Enzymatic rapid immuno-filtration assay (ERIFA) is
a version of ELISA, except that it is performed on a
nitro-cellulose (NC) membrane (Schleicher&Schuell,
Germany) included in an individual plastic cassette and
the reaction time is less than 10 min. NC membrane is
placed onto a high capacity absorbent pad (Schlei-
cher&Schuell) for capturing all reagents and solutions
used in the assay. For detecting anti-PvpA antibodies,
0.5 ml of highly purified rPvpA336 protein (1 mg/ml) as
target antigen and 0.2 ml of chicken sera diluted at 1:5
as internal control of the test were manually adsorbed
onto NC membrane. After wetting, NC membrane was
saturated with 100 ml of 1% cold-water fish gelatin
(PBST/FG) that was also used as washing and diluting
solutions for all samples and detection reagents. After
saturation of NC membrane, 50 ml of serum samples
were added: samples were flowed through the
membrane, then washed with 50 ml of PBST/FG. Fifty
microliters of AP conjugated anti-chicken IgY solution
(Sigma–Aldrich) were added and flowed through NC
membrane. The membrane was washed four times and
50 ml of BCIP/NBT substrate solution (5-bromo-4-
chloro-3-indolyl phosphate/nitro blue tetrazolium,
Sigma–Aldrich) was added. Color development was
stopped in 2 min maximum by washing solution. The
results were estimated following their intensity and
visualization time.3. Results
3.1. Cloning and DNA sequencing of the pvpA
gene and its amino acid sequence
DNA sequencing analysis of the pvpA gene
fragment integrated into pColdI vector demonstratedthat it was composed of 1008 bp encoding 336 amino
acids of M. gallisepticum PvpA cytadhesin. Based on
these results, the pvpA gene fragment insert was
named as pvpA336 and the corresponding recombi-
nant protein as rPvpA336.
In Fig. 1, a homology comparison was given with
the wild-type putative variable cytadhesin protein
PvpA of M. gallisepticum R strain (GenBank
accession no.: AAF67108). A noteworthy finding of
the homology comparison is that the rPvpA336
protein contains a deletion region of 37 amino acids
from positions 264 to 300 amino acid residues
according to the wild-type R strain without deletion.
This deletion area is distributed from the last 11 amino
acids of DR1 (direct repeated region, 264–275 aa
residues) to the beginning of DR2 region (301–352 aa
residues). In addition, the rPvpA336 protein also
possesses different amino acid residues at positions
16, 116, 124, 169, 173,174, 177, 187, 193, 209, 247,
248, 275, 287 and 288 (Fig. 1). The rPvpA336 amino
acid residues at positions 275, 287 and 288 correspond
to positions 311, 323 and 324 of the wild-type PvpA
protein. A codon insertion into the pvpA336 gene,
which encodes an additional amino acid residue at the
position 165, was also detected. Taken together, the
rPvpA336 protein presents 85% homology with the
wild-type PvpA protein.
3.2. Expression and purification of the rPvpA336
protein
Fig. 2 shows SDS-PAGE analysis of whole-cell
extract of non-induced E. coli (lane 1) harboring
recombinant expression vector pCold-pvpA336 in
comparison with those of the IPTG-induced E. coli
(lanes 2–3). High-level expression of the recombinant
rPvpA336 protein of approximately 44 kDa was
detected in the IPTG-induced bacterial cell extract,
while non-induced bacteria did not express the
recombinant protein. Purification of rPvpA336 protein
was performed following confirmation by Western
blot analysis with monoclonal anti-HisTag antibody.
The rPvpA336 protein was primarily purified by Ni-
NTA affinity chromatography and analyzed by SDS-
PAGE. To remove slight contaminants of E. coli, a
further purification was performed by SDS-PAGE
separation followed by elution of the rPvpA336
protein from the polyacrylamide gel in TNE elution
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Fig. 2. SDS-PAGE analysis of the recombinant rPvpA336 protein
expressed in E. coli. Lane 1, whole-cell extract from non-induced
bacteria. Lanes 2 and 3 represent 20 and 10 ml samples of whole-cell
extract from IPTG-induced bacteria, respectively. Lane 4, purified
rPvpA336 protein. The position of rPvpA336 proteins is indicated
by two-headed arrow. M: molecular weight marker indicated in kDa.
Fig. 1. Homology comparison of the wild-type PvpA protein (upper lanes marked with amino acid number, AAF67108 indicates GenBank
accession number) with the rPvpA336 (lower lanes, GenBank accession no.: ABJ96344). Bold letters underlined indicate different amino acid
residues between the wild-type PvpA and rPvpA336 proteins and the dashes from 264 to 300 amino acid residues represent the deletion region of
the rPvpA336.buffer. In this way, very highly purified rPvpA336
protein has been obtained (Fig. 2, lane 4) and its
molecular weight was estimated as 44 kDa in
comparison with protein molecular weight marker
(Fig. 2).
3.3. Immunoreactivity of the rPvpA336 protein
To determine immunoreactivity of the rPvpA336
protein, M. gallisepticum-positive and -negative
chicken sera previously evaluated with RSA or ELISA
were analyzed and confirmed with Western blot assay
by using whole-cell extract of M. gallisepticum Pendik
strain as antigen. The results showed that positive
chicken sera recognized several bacterial antigens of
different molecular weight, but negative sera did not
react with any antigens (data not shown). Then,
chicken sera were individually classified as M.
gallisepticum-positive or -negative confirmed sera
and used for further experiments. In order to determine
the exact location of the rPvpA336 protein, a
monoclonal anti-HisTag antibody recognizing six
histidine residues was used in Western blot analysis
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recombinant protein and its purified form.
Typical results of Western blot analysis performed
with whole-cell proteins of the IPTG-induced E. coli
and affinity purified rPvpA336 protein were shown in
Fig. 3A and B, respectively. Monoclonal anti-HisTag
antibody strongly reacted with a protein band of
44 kDa corresponding to the recombinant protein
(Fig. 3A and B, lane 1). All of the M. gallisepticum-
positive and -negative chicken sera recognized several
protein bands of E. coli cells expressing the
recombinant protein (Fig. 3A, lanes 2–8). In contrast,
only positive chicken sera reacted with 44 kDa protein
band that was also recognized by monoclonal anti-
HisTag antibody (Fig. 3A, lanes 4–8). These results
were confirmed with the purified rPvpA336 protein-
based Western blot assays (Fig. 3B). All of the positive
sera (Fig. 3B, lanes 4–8) and monoclonal anti-HisTag
antibody (Fig. 3B, lane 1) reacted less or moreFig. 3. Western blot analysis using M. gallisepticum-positive (lanes
4–8) and -negative chicken sera (lanes 2 and 3) with whole-cell
extract from IPTG-induced E. coli (A) and purified rPvpA336
protein (B). Lanes 1A and 1B, immunostaining with monoclonal
anti-HisTag antibody. Large arrows show the position of rPvpA336
protein band. M: molecular weight marker indicated in kDa.intensely with the purified recombinant protein band
of 44 kDa, while no reaction was observed with
negative sera (Fig. 3B, lanes 2 and 3). These results
showed that the recombinant rPvpA336 protein still
preserves its immunoreactivity in the purified and non-
purified forms and can be used as a diagnostic antigen.
3.4. Development of the rPvpA336-based ERIFA
test prototype
To screen anti-PvpA antibody in M. gallisepticum
(MG)-infected chicken sera in the field and limited
laboratory conditions, an enzymatic rapid immunofil-
tration assay prototype (ERIFA) has been developed
by using rPvpA336-positive or -negative sera con-
firmed with Western blot analysis. Diluted chicken
sera as internal control of the test were dotted onto NC
membrane at the left side of the cassette (C, control)
and the recombinant rPvpA336 protein as target
antigen was adsorbed at the right side of the cassette
(T, test). Development and optimization of the ERIFA
prototype was done with nine confirmed rPvpA336-
positive or -negative sera numbered from 1 to 9
(Fig. 4). Positive reaction of the internal control
(dashed arrow) in all tests indicates that the tests work
correctly. As shown in Fig. 4, rPvpA336-negative
chicken sera (samples 4 and 5) have also been found
negative whereas all positive sera have recognized less
or more intensely the rPvpA336 protein (full arrows).
Test results can be completed and evaluated in less
than 10 min. These results demonstrated that this
diagnostic prototype was very rapid and capable of
detecting the presence of anti-rPvpA336 antibodies
from MG-positive chicken sera.
3.5. Specificity of the rPvpA336-based ERIFA
prototype
Chicken sera evaluated with ELISA (Bio Check) as
MG and/or Mycoplasma synoviae (MS)-negative or -
positive were tested with the rPvpA336-based ERIFA
prototype in order to determine its species-specificity.
Five MG and MS-negative sera (samples 1–5), 10
MG-positive and MS-negative sera (samples 6–15), 7
MG-negative and MS-positive sera (samples 16–20,
23 and 24), 2 MG and MS-positive sera (samples 21
and 22) and mouse monoclonal anti-HisTag antibody
(sample 25) were evaluated with ERIFA prototype
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Fig. 4. Typical ERIFA prototype results with M. gallisepticum-positive (nos.: 1–3 and 6–9) and -negative (nos.: 4 and 5) chicken sera. Arrows
indicate internal control of the test on the left side and the recognition of the rPvpA336 on the right side.(Fig. 5). As shown in Fig. 5, internal control of the test
samples from 1 to 24 was found reactive, except the
sample 25 where anti-mouse IgG conjugate instead of
anti-chicken IgY conjugate was used in this test for
demonstrating the presence of the rPvpA336 protein.
No reaction was observed with 5 MG and MS-negative
sera (samples 1–5) and 7 MG-negative and MS-
positive sera (samples 16–20, 23 and 24) whereas 10
MG-positive and MS-negative sera (samples 6–15)
and 2 MG and MS-positive sera (samples 21 and 22)
have reacted less or more intensely with the rPvpA336
protein (full arrows in Fig. 5). Positive reaction
intensity of chicken sera with the rPvpA336 protein
was found uncorrelated with their MG–ELISA titer.
For example, the sample 15 with low response in MG–
ELISA reacted as intense as the sample 14 having high
response in MG–ELISA. These results demonstrate
that the rPvpA336-based ERIFA test allows rapid and
species-specific screening of sera from M. gallisepti-
cum-infected chickens.4. Discussion
Immunofiltration assay, also called as ‘‘flow-
through assay’’, is a well-known method and various
tests have been developed and widely used as sensitive
diagnostic tools in human medicine (Xiao et al., 2003;
Foglia et al., 2004; Daniel et al., 2005; O’Connell
et al., 2006). Though being easily applicable to the
diagnosis purposes and adaptable to the field and
limited laboratory conditions, the use of this
immunoassay method is uncommon in veterinary
medicine (Abdel-Hamid et al., 1999; Yamazaki et al.,
2004). In this study, an enzymatic rapid immunofil-
tration assay (ERIFA) prototype was developed to
screen M. gallisepticum-infected chickens by using
the purified recombinant PvpA protein known as a
species-specific antigen (Yogev et al., 1994; Bogus-
lavsky et al., 2000). For this purpose, a large fragment
of pvpA gene composed of 1008 nucleotides encoding
a polypeptide of 336 amino acid residues (rPvpA336)
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Fig. 5. Specificity of the rPvpA336-based ERIFA test by using M. gallisepticum (MG) and M. synoviae (MS)-negative sera (samples 1–5), MG-
positive and MS-negative sera (samples 6–15), MG-negative and MS-positive sera (samples 16–20, 23 and 24), MG and MS-positive sera
(samples 21 and 22) and mouse monoclonal anti-HisTag antibody (sample 25). Arrows indicate internal control of the test on the left side and the
recognition of the rPvpA336 on the right side.was cloned into pColdI vector, expressed in E. coli and
affinity purified. Homology comparison of the
recombinant rPvpA336 protein with the wild-type
PvpA protein (GenBank accession no.: AAF67108)
revealed the presence of a deletion region of 37 amino
acids taking place at the proline-rich C-terminal
region from the last 11 amino acids (residues 264–
275) of the direct repeat region DR1 to the beginning
of DR2 region (Fig. 1). This deletion was localized
within the hot-spot deletion domain of the pvpA gene
as previously described for various M. gallisepticum
strains (Boguslavsky et al., 2000; Liu et al., 2001) and
as its result, relative molecular weight of the
rPvpA336 protein was found as 44 kDa in SDS-
PAGE analysis (Fig. 2). In spite of the deletion regionand divergence in 15 amino acid residues, the
recombinant rPvpA336 protein presents very high
level of homology with the wild-type PvpA protein.
Immunostaining of a 44 kDa protein band in crude
and purified forms (Fig. 3A and B) with monoclonal
anti-HisTag antibody confirmed the expression and
location of the recombinant rPvpA336 protein derived
from MG. Recognition of the 44 kDa protein band in
the same Western blot assays by the chicken sera
confirmed as MG-positive, but not with negative sera
strongly suggests that the recombinant rPvpA336
protein still preserves its antigenic properties while it
contains a deletion region of 37 amino acids. This
result is not surprising because the reactivity of several
native PvpA proteins containing various deletions
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analysis (Boguslavsky et al., 2000). Primary evidence
of the immunogenicity of PvpA protein has been
demonstrated by Western blot analysis with a serum
pool of infected chickens recognizing the bacterial
surface antigens obtained only from PvpA producing
clonal variants of M. gallisepticum R strain, but not
from PvpA-negative clones (Yogev et al., 1994).
Besides, the immunoreactivity of the recombinant
PvpA protein has also been shown with E. coli
bacterial (Boguslavsky et al., 2000) and Avipox viral
recombinant expression systems (Saitoh et al., 1999).
Likely, its highly hydrophilic outer-membrane domain
within 100–382 amino acid residues of the wild-type
molecule (Boguslavsky et al., 2000) may contain
several immunodominant domains recognized by the
natural host immune response, but they have not yet
been determined. In this respect, our preliminary
results (data not shown) indicate that their location
could essentially be present exterior to the direct
repeat regions DR1 and DR2, probably within the
segments encompassing 110–220 and 350–382 amino
acid residues of the wild-type PvpA protein.
From the results of this study and those previously
described for PvpA (Yogev et al., 1994; Saitoh et al.,
1999; Boguslavsky et al., 2000), the recombinant
rPvpA336 protein can be considered as a highly
immunoreactive species-specific molecule. There-
fore, it was used as a target antigen in the development
of a diagnostic prototype to avoid inter-species cross-
reactivity frequently observed with the whole-cell,
their extracts or surface molecules harboring identical
antigenic determinants (Noormohammadi et al.,
1998; Dufour-Gesbert et al., 2001; Bencina, 2002;
Feberwee et al., 2005). Cross-reactions between the
sera from chicken infected with M. gallisepticum and
M. synoviae, two major avian mycoplasmosis agents
sharing common antigenic determinants within their
respective pMGA1.7 and VlhA surface proteins, have
been overcome by an immunoassay based on the
recombinant fusion protein including a species-
specific domain of MSPB encoded by vlhA gene of
M. synoviae (Noormohammadi et al., 1999). In
addition, use of recombinant proteins mimicking
species-specific antigens or antigenic determinants in
the development of diagnostic assays has several
advantages over those obtained from cultivated
bacteria (Noormohammadi et al., 1999; Okadaet al., 2005; Ben Abdelmoumen Mardassi et al.,
2007).
In our knowledge, no species-specific recombinant
antigen-based immunoassay models adapted to the
field and limited laboratory conditions for screening
M. gallisepticum-infected chickens was described in
the literature. Considering species-specific and immu-
nogenic properties of the PvpA protein (Yogev et al.,
1994; Levisohn et al., 1995; Boguslavsky et al., 2000),
usefulness of the rPvpA336 protein as a standardized
species-specific antigen has been demonstrated not
only by Western blot analysis but also by ERIFA test
(Figs. 3–5). In fact, with the ERIFA test, only MG-
positive and MS-negative or MG- and MS-positive
chicken sera were found reactive but not MG- and MS-
negative or MG-negative and MS-positive sera
(Fig. 5). Despite a limited number of chicken sera
were tested to evaluate the ERIFA prototype, these
preliminary results indicate that the rPvpA336-based
ERIFA test is able to avoid the false positive reactions
for the screening of MG-positive sera. In contrast, the
false negative reactions with the rPvpA336-based
ERIFA test may not be excluded since they could be
due to the infections with some MG strains lacking
PvpA protein (Bencina et al., 2003). To overcome the
possibility of non-detection of the infections due to
MG strains lacking PvpA protein, the ERIFA test
could therefore be enriched with a second highly
conserved and immunogenic antigen of M. gallisepti-
cum or its species-specific antigenic determinants.
Although MG infections caused by PvpA lacked
strains are extremely rare, antigenic variability due to
the size- and phase-variation of the PvpA protein
among MG strains is more frequent (Levisohn et al.,
1995; Boguslavsky et al., 2000). As the PvpA proteins
from various MG strains contain a number of common
immunodominant epitopes, some MG-infected chick-
ens from the same flock could likely develop
detectable antibody response to the PvpA variant
proteins including the truncated ones.
In conclusion, the adaptability of the enzymatic
rapid immunofiltration assay to M. gallisepticum
diagnosis has been shown through the detection of
anti-PvpA antibody with ERIFA diagnostic proto-
type. This immunoassay prototype can already be
considered as a promising field-diagnostic tool since
its application is no longer than 10 min without any
specific equipment and the results are evaluated as
Ö. Büyüktanır et al. / Veterinary Microbiology 129 (2008) 139–149148positive or negative in function of the intensity and
appearance time of the color reaction. Specificity and
high sensitivity of the assay are assured by the
species-specific rPvpA336 protein and the enzymatic
reaction. Taking these advantages into account, such
a rapid, cost-effective and species-specific diagnostic
tool has the potential of being included in the panel of
M. gallisepticum screening tests in the field and
limited laboratory conditions. Nevertheless, its
potential as a field test needs to be validated with
more sera from chickens experimentally and natu-
rally infected by M. gallisepticum, M. synoviae and
M. meleagridis. This investigation is currently
undergoing in our laboratory.Acknowledgment
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Ben Abdelmoumen Mardassi, B., Béjaoui Khiari, A., Oussaief, L.,
Landoulsi, A., Brik, C., Mlik, B., Amouna, F., 2007. Molecular
cloning of a Mycoplasma meleagridis specific antigenic domain
endowed with a serodiagnostic potential. Vet. Microbiol. 119,
31–41.
Bencina, D., 2002. Haemagglutinins of pathogenic avian mycoplas-
mas. Avian Pathol. 31, 535–547.
Bencina, D., Mrzel, I., RoJs, O.Z., Bidovec, A., Dovc, A., 2003.
Characterisation of Mycoplasma gallisepticum strains involved
in respiratory disease in pheasants and peafowl. Vet. Rec. 152,
230–234.
Boguslavsky, S., Menaker, D., Lysnyansky, I., Liu, T., Levisohn, S.,
Rosengarten, R., Garcia, M., Yogev, D., 2000. Molecular char-
acterization of the Mycoplasma gallisepticum pvpA gene which
encodes a putative variable cytadhesin protein. Infect. Immun.
68, 3956–3964.
Daniel, H.D., Abraham, P., Raghuraman, S., Vivekanandan, P.,
Subramaniam, T., Sridharan, G., 2005. Evaluation of a rapid
assay as an alternative to conventional enzyme immunoassays
for detection of hepatitis C virus-specific antibodies. J. Clin.
Microbiol. 43, 1977–1978.
Dufour-Gesbert, F., Kempf, I., De Simone, F., Kobisch, M., 2001.
Antigen heterogeneity and epitope variable expression in Myco-
plasma meleagridis isolates. Vet. Microbiol. 78, 261–273.Feberwee, A., Mekkes, D.R., de Wit, J.J., Hartman, E.G., Pijpers, A.,
2005. Comparison of culture, PCR, and different serologic tests
for detection of Mycoplasma gallisepticum and Mycoplasma
synoviae infections. Avian Dis. 49, 260–268.
Foglia, G., Royster IV, G.D., Wasunna, K.M., Kibaya, R., Malia,
J.A., Calero, E.K., Sateren, W., Renzullo, P.O., Robb, M.L.,
Birx, D.L., Michael, N.L., 2004. Use of rapid and conventional
testing technologies for human immunodeficiency virus type 1
serologic screening in a rural Kenyan reference laboratory. J.
Clin. Microbiol. 42, 3850–3852.
Goh, M.S., Gorton, T.S., Forsyth, M.H., Troy, K.E., Geary, S.J.,
1998. Molecular and biochemical analysis of a 105 kDa Myco-
plasma gallisepticum cytadhesin (GapA). Microbiology 144,
2971–2978.
Hnatow, L.L., Keeler Jr., C.L., Tessmer, L.L., Czymmek, K.,
Dohms, J.E., 1998. Characterization of MGC2, a Mycoplasma
gallisepticum cytadhesin with homology to the Mycoplasma
pneumoniae 30-kilodalton protein P30 and Mycoplasma geni-
talium P32. Infect. Immun. 66, 3436–3442.
Keeler Jr., C.L., Hnatow, L.L., Whetzel, P.L., Dohms, J.E., 1996.
Cloning and characterization of a putative cytadhesin gene
(mgc1) from Mycoplasma gallisepticum. Infect. Immun. 64,
1541–1547.
Laemmli, U.K., 1970. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature (London) 227,
680–685.
Levisohn, S., Rosengarten, R., Yogev, D., 1995. In vivo variation of
Mycoplasma gallisepticum antigen expression in experimentally
infected chickens. Vet. Microbiol. 45, 219–231.
Liu, T., Garcia, M., Levisohn, S., Yogev, D., Kleven, S.H., 2001.
Molecular variability of the adhesin-encoding gene pvpA among
Mycoplasma gallisepticum strains and its application in diag-
nosis. J. Clin. Microbiol. 39, 1882–1888.
Noormohammadi, A.H., Markham, P.F., Duffy, M.F., Whithear,
K.G., Browning, G.F., 1998. Multigene families encoding the
major hemagglutinins in phylogenetically distinct mycoplas-
mas. Infect. Immun. 66, 3470–3475.
Noormohammadi, A.H., Markham, P.F., Markham, J.F., Whithear,
K.G., Browning, G.F., 1999. Mycoplasma synoviae surface
protein MSPB as a recombinant antigen in an indirect ELISA.
Microbiology 145, 2087–2094.
O’Connell, R.J., Agan, B.K., Anderson, S.A., Malia, J.A., Michael,
N.L., 2006. Sensitivity of the Multispot HIV-1/HIV-2 rapid test
using samples from human immunodeficiency virus type 1-
positive individuals with various levels of exposure to highly
active antiretroviral therapy. J. Clin. Microbiol. 44, 1831–1833.
Okada, M., Asai, T., Futo, S., Mori, Y., Mukai, T., Yazawa, S., Uto,
T., Shibata, I., Sato, S., 2005. Serological diagnosis of enzootic
pneumonia of swine by a double-sandwich enzyme-linked
immunosorbent assay using a monoclonal antibody and recom-
binant antigen (P46) of Mycoplasma hyopneumoniae. Vet.
Microbiol. 105, 251–259.
Saitoh, S., Ohkawa, S., Saeki, S., Ohsawa, I., Funato, H., Iritani, Y.,
Aoyama, S., Takahashi, K., 1999. Recombinant Avipox virus
encoding polypeptide of Mycoplasma gallisepticum, and uti-
lized a live vaccine. US Patent and Trade Mark Office No.:
5,871,742.
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